Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.
- Clinical Supply's Role In Driving Success In Decentralized Trials
- The 2020 Pediatric Mandate That Shook Up Oncology Research
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases
- Takeda Keeps Patients The Focus Of PDTs For Rare Disease
- Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights
GUEST COLUMNISTS
-
![Man with nurse in clinic-GettyImages-2244535535]( "Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights")
Designing Patient-Centric Recruitment Pathways With Real-Time Adherence InsightsLearn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
-
![Inserting catheter into vein-GettyImages-1772781376]( "Navigating The Challenges Of Cell Therapy Clinical Trials")
Navigating The Challenges Of Cell Therapy Clinical TrialsIN8bio CEO William Ho shares how they overcame operational challenges unique to cell therapy research, including how to carefully conduct site expansion and onboard new sites without disrupting study timelines.
-
![Time Management-GettyImages-1212135701]( "Patient Input Is A Must — Even Under Time And Money Constraints")
Patient Input Is A Must — Even Under Time And Money ConstraintsStacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
-
![Cloud computing digita-GettyImages-2161057424]( "From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials")
From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical TrialsDiscover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.
-
![A Healing Touch-GettyImages-1764823372]( "Need An Investigator? There's An APP — Advanced Practice Provider — For That")
Need An Investigator? There's An APP — Advanced Practice Provider — For ThatFewer available principal investigators (PIs) is not a new problem for clinical research, but it does necessitate some new and creative solutions. Learn how advanced practice providers (APPs) might help fill the PI gap.
-
![Alzheimers disease-GettyImages-648706624]( "Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data")
Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And DataCognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.
-
![GettyImages-1286971245-FDA]( "An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority Voucher")
An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority VoucherDompé Chief Development Officer Ahmed Enayetallah reveals how the team earned the FDA's new Commissioner’s National Priority Voucher.
-
![World globe with pushpins-GettyImages-1289685049]( "A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales")
A Tale Of Two Sites: How FastWave Ran Trials In Distinct LocalesNo two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.
CLINICAL TRIAL WHITE PAPERS
-
![Antibodies And Cancer Cell GettyImages-1410479280]( "Antibody-Drug Conjugates Clinical Trials 2024")
Antibody-Drug Conjugates Clinical Trials 2024Gain comprehensive insights into Antibody-Drug Conjugates (ADCs) with our 2024 clinical trial report, offering a deep dive into new drug developments and market trends shaping cancer treatment.
-
Digital Endpoint Resource Guide: Sleep Disorders12/10/2025
Sensor-driven digital endpoints track sleep patterns and disruptions, standardize trial outcomes, and enable remote monitoring that reduces patient burden while improving treatment-response insights.
-
Best Practices For Harmonizing Global Data Disclosure2/20/2024
Learn how sponsors can address the challenge of submitting clinical trial data in a consistent and compliant manner by examining internal processes to identify and close gaps.
-
The Complexities Of Effective Patient Retention In Clinical Trials11/7/2025
Identifying and enrolling the right-fit patients from the outset is essential, but so is implementing comprehensive retention strategies that prioritize patient comfort, trust, and ongoing engagement.
-
Off-Script FDA: How Smart Teams Pivot, Escalate, And Progress7/15/2025
Dr. Rachel Sherman, former Principal Deputy Commissioner of the FDA, explains the rules of engagement for working with today’s FDA.
-
Deal-Making Volume Slowed In 20235/15/2024
This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Use Of Epiontis ID In A Phase 2 Psoriasis Trial9/25/2025
Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.
-
Accelerate Your Oncology Breakthroughs4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
Post-Market Safety And Risk Management in DMD4/11/2025
The pharmaceutical company specializing in rare neurological diseases sought solutions after encountering significant hurdles in post-market safety surveillance.
-
Increasing Efficiency And Reducing Drug Waste10/2/2025
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Enhance Access And Improve Retention In Rare Disease Trials With HTS4/17/2025
Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs1/6/2025
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
NEWSLETTER ARCHIVE
- 12.15.25 -- New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact
- 12.13.25 -- Best Of November
- 12.12.25 -- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- 12.11.25 -- FDA First: Dompé Secures a Commissioner's National Priority Voucher
- 12.10.25 -- What The FDA Says About Investigator Responsibilities In DCTs
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![Medical research, technology, innovation, AI-GettyImages-2226144959]( "The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity")
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
![Man with nurse in clinic-GettyImages-2244535535]( "Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights")
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
-
![Time Management-GettyImages-1212135701]( "Patient Input Is A Must — Even Under Time And Money Constraints")
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
FOCUS ON PATIENTS
-
![Medical research, technology, innovation, AI-GettyImages-2226144959]( "The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity")
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
![Blood plasma donation during coronavirus-GettyImages-1282388401]( "Takeda Keeps Patients The Focus Of PDTs For Rare Disease")
Takeda’s Kristina Allikmets, MD, Ph.D, shares how her team incorporates patient voices and prioritizes innovations to reduce treatment burden, expand access, and develop plasma-derived therapies for rare diseases.
-
![Man with nurse in clinic-GettyImages-2244535535]( "Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights")
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
